The UK, the UPC, and the EPO: Building a Coordinated European Litigation Strategy

Discuss the strategic deployment of European litigation venues for US pharma companies, including the UK High Court litigation, UPC proceedings and EPO
9
All information is kept strictly confidential. Please do not distribute.
Please contact: [email protected] for further information.
oppositions, and compare the impacts on injunction risk, cost exposure, and global settlement dynamics.